Insufficient scRNA-seq data for expression of CARD17P at single-cell level.
Insufficient scRNA-seq data for expression of CARD17P at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 95% | 13.61 | 228 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 25.10 | 764 / 929 | 0% | 0 | 0 / 0 |
lung | 46% | 4.19 | 266 / 578 | 28% | 0.85 | 324 / 1155 |
esophagus | 37% | 11.89 | 536 / 1445 | 36% | 1.32 | 66 / 183 |
skin | 66% | 17.97 | 1191 / 1809 | 7% | 0.13 | 33 / 472 |
prostate | 38% | 3.05 | 93 / 245 | 1% | 0.03 | 5 / 502 |
tonsil | 0% | 0 | 0 / 0 | 38% | 0.86 | 17 / 45 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.72 | 10 / 29 |
uterus | 3% | 0.59 | 5 / 170 | 30% | 1.09 | 137 / 459 |
intestine | 23% | 2.73 | 222 / 966 | 7% | 0.14 | 37 / 527 |
bladder | 5% | 2.52 | 1 / 21 | 16% | 0.66 | 80 / 504 |
breast | 3% | 0.16 | 12 / 459 | 10% | 0.25 | 112 / 1118 |
stomach | 6% | 0.38 | 21 / 359 | 5% | 0.10 | 15 / 286 |
thymus | 7% | 0.64 | 44 / 653 | 2% | 0.04 | 14 / 605 |
kidney | 6% | 0.62 | 5 / 89 | 2% | 0.04 | 17 / 901 |
adipose | 7% | 0.49 | 84 / 1204 | 0% | 0 | 0 / 0 |
liver | 4% | 0.15 | 8 / 226 | 1% | 0.03 | 5 / 406 |
pancreas | 1% | 0.03 | 2 / 328 | 4% | 0.06 | 7 / 178 |
ovary | 1% | 0.02 | 1 / 180 | 3% | 0.04 | 13 / 430 |
blood vessel | 3% | 0.20 | 37 / 1335 | 0% | 0 | 0 / 0 |
heart | 2% | 0.14 | 19 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 0.03 | 2 / 258 | 0% | 0.09 | 1 / 230 |
brain | 1% | 0.03 | 19 / 2642 | 0% | 0.00 | 1 / 705 |
muscle | 0% | 0.02 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
GO_0089720 | Molecular function | caspase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CARD17P |
Protein name | Putative caspase recruitment domain-containing protein 17P (Caspase-1 inhibitor INCA) (Inhibitory caspase recruitment domain protein) |
Synonyms | CARD17 INCA |
Description | FUNCTION: Regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, do not induce NF-kappa-B activation. . |
Accessions | Q5XLA6 |